- Home
- KNSA vs KEN Comparison
KNSA vs KEN Comparison
Compare KNSA & KEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- KEN
- Stock Information
- Founded
- KNSA 2015
- KEN 2014
- Country
- KNSA United Kingdom
- KEN Singapore
- Employees
- KNSA N/A
- KEN N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- KEN Electric Utilities: Central
- Sector
- KNSA Health Care
- KEN Utilities
- Exchange
- KNSA Nasdaq
- KEN Nasdaq
- Market Cap
- KNSA 2.6B
- KEN 2.3B
- IPO Year
- KNSA 2018
- KEN N/A
- Fundamental
- Price
- KNSA $35.92
- KEN $42.84
- Analyst Decision
- KNSA Strong Buy
- KEN
- Analyst Count
- KNSA 6
- KEN 0
- Target Price
- KNSA $40.83
- KEN N/A
- AVG Volume (30 Days)
- KNSA 392.6K
- KEN 11.4K
- Earning Date
- KNSA 10-28-2025
- KEN 08-08-2025
- Dividend Yield
- KNSA N/A
- KEN 11.19%
- EPS Growth
- KNSA N/A
- KEN N/A
- EPS
- KNSA 0.07
- KEN 9.36
- Revenue
- KNSA $529,332,000.00
- KEN $774,304,000.00
- Revenue This Year
- KNSA $37.21
- KEN N/A
- Revenue Next Year
- KNSA $11.99
- KEN N/A
- P/E Ratio
- KNSA $542.28
- KEN $4.52
- Revenue Growth
- KNSA 56.18
- KEN 5.38
- 52 Week Low
- KNSA $17.82
- KEN $24.27
- 52 Week High
- KNSA $37.34
- KEN $49.99
- Technical
- Relative Strength Index (RSI)
- KNSA 60.14
- KEN 41.63
- Support Level
- KNSA $35.29
- KEN $41.50
- Resistance Level
- KNSA $37.34
- KEN $47.29
- Average True Range (ATR)
- KNSA 1.00
- KEN 0.62
- MACD
- KNSA -0.15
- KEN -0.36
- Stochastic Oscillator
- KNSA 65.30
- KEN 21.51
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About KEN Kenon Holdings Ltd.
Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include OPC Power Plants, CPV Group, and ZIM. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.